Clinical Trials Logo

Rhinitis clinical trials

View clinical trials related to Rhinitis.

Filter by:

NCT ID: NCT01116778 Completed - Clinical trials for Perennial Allergic Rhinitis

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis

PAR
Start date: May 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of probiotics eN-Lac® capsules (Lactobacillus paracasei GMNL-32) for the treatment of children with perennial allergic rhinitis(PAR).

NCT ID: NCT01115595 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

Start date: March 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to study the efficacy of allergen injection immunotherapy for allergic rhinitis by - symptoms score - medication score - quality of life - immunologic test from blood

NCT ID: NCT01113697 Completed - Asthma Clinical Trials

Genetics of the Early and Late Response to Allergen Challenge

Start date: August 2009
Phase:
Study type: Observational

The investigators are investigating the early and late responses to allergen challenge. The research participants who the investigators will study (from three cohorts) will be part of independently-approved studies involving allergen challenge. Due to the uniqueness of the cohorts for novel genetic study, it is logical that the investigators should initially undertake hypothesis-generating experiments. The investigators will obtain blood samples from the participants, both pre-challenge and post-challenge. The investigators will determine gene expression and protein differences between these samples, and investigate if there are inherited genetic differences between individuals that may predict their specific responses to allergens.

NCT ID: NCT01110837 Recruiting - Allergic Rhinitis Clinical Trials

Repeat Dose Nasal Allergen Challenge

Start date: April 2010
Phase: N/A
Study type: Interventional

What happens in the nose during an allergic reaction? Are there changes that a new drug could treat? What is the best way to test new drugs?The response of the nose to being exposed to cat allergen in someone who is allergic to cats. Symptoms, level of nasal blockage and cell and chemical changes that occur in the nose will be studied before and after being exposed to cat allergen. The investigators will also to see if giving repeated doses of allergen increases the response.Allergic rhinitis is a very common illness. There are over 500 million patients worldwide. It can increase the severity of associated asthma. Currently available drugs do not completely treat the symptoms. New treatments need to be found. A way of testing these drugs is very important. This study will investigate causes of the symptoms that occur in allergic rhinitis. It will also validate a proposed model to test new drugs. the Study Hypothesis is that a model of nasal allergen challenge shows an increased response (priming) with repeat challenges as determined by changes in nasal peak inspiratory flow.

NCT ID: NCT01108783 Completed - Clinical trials for Seasonal Allergic Rhinitis

A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

Start date: April 2003
Phase: Phase 3
Study type: Interventional

The objective of the study was to determine the efficacy and tolerability of 20 mg of Bilastine, compared to Desloratadine and placebo for the treatment of Seasonal Allergic Rhinitis.

NCT ID: NCT01104012 Completed - Rhinitis, Allergic Clinical Trials

Validation of Proteomic Analyses for Allergic Asthma and Rhinitis

VAPARA
Start date: May 2010
Phase: N/A
Study type: Observational

The purpose of this study is to verify and validate the intrinsic diagnostic value in terms of sensitivity and specificity of proteomic profiles determined during a pre-study for discriminating between allergy related asthma and allergy related rhinitis.

NCT ID: NCT01103934 Completed - Clinical trials for Seasonal Allergic Rhinitis

Vitamin D Plus Fluticasone Propionate

Start date: June 2010
Phase: Phase 4
Study type: Interventional

The objectives of this study would be to see if the addition of vitamin D to fluticasone propionate provides greater symptomatic relief in patients with seasonal allergic rhinitis compared to fluticasone propionate treatment alone.

NCT ID: NCT01103050 Completed - Allergic Rhinitis Clinical Trials

A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine

Start date: March 22, 2010
Phase: Phase 2
Study type: Interventional

This study will determine the capacity of more frequent dosing of QAV680 to suppress allergic inflammation. The study will investigate the paradigm of multiple receptor antagonism in allergic disease by combining QAV680 with a second generation H1 histamine receptor antagonist to assess possible additive or synergistic anti-allergic effects of the two compound classes.

NCT ID: NCT01096615 Completed - Rhinitis Clinical Trials

Effect Of Probiotic Lactobacillus Paracasei Lp-33 For The Management Of Rhinitis In People Sensitized To Allergens

BionAtlanta
Start date: April 2010
Phase: Phase 3
Study type: Interventional

The aim of the study is to show an improvement of quality of life on the 5th week of product consumption (probiotic Lactobacillus paracasei LP-33)(as assessed by RQLQ global score) in subjects with persistent allergic rhinitis currently treated with Loratadine or oral anti-histaminic treatment.

NCT ID: NCT01085916 Unknown status - Asthma Clinical Trials

Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia

Start date: April 2010
Phase: N/A
Study type: Observational

The purpose of this cross-sectional survey study is to describe the prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia.